$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,700 Today
SIGA Technologies (NASDAQ:SIGA) has outperformed the market over the past 5 years by 26.33% on an annualized basis producing an average annual return of 36.11%. Currently, SIGA Technologies has a market capitalization of $1.04 billion.
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be…
‘Monkeypox Outbreak Shows Signs of Cooling in U.S. and Globally’ -WSJ Report
https://www.wsj.com/articles/monkeypox-outbreak-shows-signs-of-cooling-in-u-s-and-globally-11661526042?mod=e2tw
Why Several Chinese Stocks Traded Higher; Here Are 58 Biggest Movers From Yesterday
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018.
Researchers Behind COVID-19 RECOVERY Trial Launch New Monkeypox Treatment Trial
The U.K.-based Oxford University researchers behind the COVID-19 treatment trial RECOVERY are back again, this time for a randomized…
Oxford University PLATINUM Trial to Confirm Whether SIGA Technologies’ Tecovirimat is an Effective Treatment for Monkeypox
-Reuters
https://www.reuters.com/business/healthcare-pharmaceuticals/british-scientists-behind-key-covid-trial-launch-study-test-monkeypox-treatment-2022-08-23/